Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000312069-26-000266·Cartesian Therapeutics, Inc.
Schedule 13G ownership disclosure
Cartesian Therapeutics Inc
COMMON-STOCK · CUSIP: 816212302
Event date: 2026-09-30
- Filing-level shares
- 7,233
- Percent of class
- 0.02%
- Barclays PLC
Shares: 7,233 · Class: 0.02%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000312069-26-000266
- Form type
- SCHEDULE 13G/A
- Filer
- Cartesian Therapeutics, Inc.
- CIK
- CIK 1453687
- Filed
- Nov 06, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership